Terapia génica
La terapia génica administra una copia funcional de un gen, o corrige uno defectuoso, generalmente una sola vez y para toda la vida. Fabricar el vector que la administra suele ser más difícil que diseñar la terapia.
132 acciones
| # | Nombre | Posición | Valor operado |
Acciones del tema |
% del portafolio | Estado | |
|---|---|---|---|---|---|---|---|
| 76 |
Orbis Allan Gray
Hamilton,
Bermuda
| USD 250 M | -USD 50.2 M | 1 | 0.83% | Reducidas |
|
| 77 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| USD 246 M | +USD 17.1 M | 67 | 0.04% | Aumentadas |
|
| 78 |
Woodline Partners
San Francisco,
California
| USD 241 M | +USD 25.6 M | 31 | 0.73% | Aumentadas |
|
| 79 |
BNP Paribas Financial Markets
Paris,
France
| USD 239 M | -USD 88.7 M | 69 | 0.08% | Reducidas |
|
| 80 |
UBS AM
Chicago,
Illinois
| USD 236 M | +USD 73.9 M | 41 | 0.04% | Aumentadas |
|
| 81 |
AQR Capital Management
Greenwich,
Connecticut
| USD 235 M | -USD 150 M | 45 | 0.07% | Reducidas |
|
| 82 |
Aberdeen Group
Edinburgh,
United Kingdom
| USD 229 M | -USD 10.8 M | 14 | 0.32% | Reducidas |
|
| 83 |
GW&K Investment Management
Boston,
Massachusetts
| USD 224 M | +USD 40 M | 7 | 1.9% | Aumentadas |
|
| 84 |
Arch Venture Management
Chicago,
Illinois
| USD 222 M | +USD 221 M | 3 | 13.76% | Aumentadas |
|
| 85 |
Lord, Abbett & Co
Jersey City,
New Jersey
| USD 220 M | +USD 5.05 M | 5 | 0.66% | Aumentadas |
|
| 86 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| USD 217 M | +USD 46.7 M | 60 | 0.02% | Aumentadas |
|
| 87 |
Armistice Capital
New York
| USD 214 M | +USD 30.2 M | 11 | 2.63% | Aumentadas |
|
| 88 |
Barclays
London,
United Kingdom
| USD 214 M | +USD 110 M | 69 | 0.04% | Aumentadas |
|
| 89 |
Federated Hermes
Pittsburgh,
Pennsylvania
| USD 212 M | +USD 28.7 M | 20 | 0.3% | Aumentadas |
|
| 90 |
Paradigm Biocapital Advisors
New York
| USD 212 M | +USD 245 M | 2 | 4.21% | Aumentadas |
|
| 91 |
Frazier Life Sciences Management
Palo Alto,
California
| USD 210 M | -USD 126 M | 5 | 5.22% | Reducidas |
|
| 92 |
American Century Companies
Kansas City,
Missouri
| USD 207 M | +USD 6.99 M | 31 | 0.09% | Aumentadas |
|
| 93 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| USD 206 M | -USD 5.49 M | 38 | 0.16% | Reducidas |
|
| 94 |
Aisling Capital Management
New York
| USD 204 M | -USD 117 M | 2 | 68.04% | Reducidas |
|
| 95 |
AllianceBernstein
Nashville,
Tennessee
| USD 197 M | -USD 58.3 M | 39 | 0.06% | Reducidas |
|
| 96 |
Marshall Wace
London,
United Kingdom
| USD 195 M | -USD 166 M | 43 | 0.17% | Reducidas |
|
| 97 |
EcoR1 Capital
San Francisco,
California
| USD 188 M | -USD 7.86 M | 5 | 8.34% | Reducidas |
|
| 98 |
KCM
Kynam Capital Management
Princeton,
New Jersey
| USD 186 M | +USD 130 M | 3 | 10.31% | Aumentadas |
|
| 99 |
HRT Financial
New York
| USD 178 M | +USD 62.5 M | 31 | 0.31% | Aumentadas |
|
| 100 |
Russell Investments Group
London,
United Kingdom
| USD 174 M | +USD 30.5 M | 49 | 0.15% | Aumentadas |
|